Skip to main content

Police investigate Pakistan heart drug deaths

At least 36 people with cardiovascular problems have died in a Lahore hospital over the past three weeks because of faulty drugs, Pakistani officials say.
Police have arrested the owners of two local pharmaceutical firms that supplied the drugs to the government-owned Punjab Institute of Cardiology.
Neither of the two firms have commented on the allegations.
Doctors believe one or more of at least four drugs given to patients at the institute directly led to their deaths.
The drugs were purchased at competitive rates and were allegedly offered to patients free of cost.
"More than 100 patients brought to various hospitals in Lahore for suspected drug reactions have all been recently under treatment at Punjab Institute of Cardiology, and were given these drugs," Punjab provincial Health Secretary Jehanzeb Khan said on Monday.
Dr Javed Ikram of the Allama Iqbal Medical College - one of the biggest medical colleges in the country - told the BBC that the drug reaction was initially marked by rapid depletion of bone marrow, white cells and platelets - causing bleeding and death.
The BBC's M Ilyas Khan in Islamabad says the Pakistani pharmaceuticals market is intensely competitive, with local companies competing with multinationals for hospital contracts.
This is thought to be the first time that drugs provided by Pakistani companies are alleged to have been below standard, our correspondent says adds.
Officials say they have sealed off one pharmaceutical firm and are sending the four drugs for testing abroad to determine which one of them caused the reaction, and why.
In a statement the Pakistan Medical Association urged the government to buy life-saving drugs from other suppliers.
Hospital sources told BBC if they do not buy drugs from the lowest bidder, they can be taken to court by local pharmaceutical companies and even be issued with an injunction against all future purchases.

 

Comments

Post a Comment

Popular posts from this blog

Contact Precautions May Have Unintended Consequences

Contact precautions, including gloves, gowns, and isolated rooms, have helped stem the transmission of hospital pathogens but have also had some negative consequences, according to findings from a new study. Healthcare worker (HCWs) visited patients on contact precautions less frequently than other patients and spent less time with those patients when they did visit, report Daniel J. Morgan, MD, from the University of Maryland School of Medicine and the Veterans Affairs (VA) Maryland Health Care System, Baltimore, and colleagues. Moreover, patients on contact precautions also received fewer outside visitors. "Less contact with HCWs suggests that other unintended consequences of contact precautions still exist," Dr. Morgan and coauthors write. "The resulting decrease in HCW contact may lead to increased adverse events and a lower quality of patient care due to less consistent patient monitoring and poorer adherence to standard adverse event prevention methods (such...
Post a Comment
Read more

Obama Renominates Tavenner to Be CMS Chief

President Barack Obama yesterday renominated Marilyn Tavenner, the acting administrator of the Centers for Medicare & Medicaid Services (CMS), to serve in that post without the caveat of "acting" attached to it. If the Senate approves her nomination, Tavenner will be the first confirmed, full-fledged CMS administrator since Mark McClellan, MD, PhD, stepped down from that position in October 2006, during the George W. Bush administration. Dr. McClellan's successors either were acting administrators or, in the case of Donald Berwick, MD, who was Tavenner's immediate predecessor, a recess appointment. As illustrated by Dr. Berwick's  CMS history , Senate confirmation can be tough to get when one party has enough votes to filibuster and otherwise stymie a nomination by an opposing party's president. That was the case when Obama nominated Dr. Berwick, whom Senate Republicans portrayed as an advocate of healthcare rationing, a characterization denied by t...
Post a Comment
Read more

Secondary Prevention: Clinical Approaches to Managing the Higher-Risk Patient with Heart Disease

INCIDENCE/PREVALENCE/BURDENS ASSOCIATED WITH CARDIOVASCULAR DISEASE (CVD) The prevention of an initial and recurrent cardiovascular event and other complications, such as diabetes and kidney failure [also known as end-stage renal disease (ESRD) or chronic kidney disease (CKD) stage 5] is an important goal in patients with a history of CVD. Each year, approximately 185,000 Americans suffer a recurrent stroke, approximately 470,000 will have a recurrent coronary attack, and an estimated 325,000 will suffer a recurrent myocardial infarction. [1]  Secondary prevention strategies offer the opportunity to prevent further complications and improve outcomes by early detection and management of common comorbidities. The burden on public health and the costs associated with chronic illnesses such as CVD, CKD, and diabetes remain high. An estimated 82.6 million American adults (1 in 3) have 1 or more types of CVD. [1]  Heart failure is the fastest-growing clinical cardiac disease ...
Post a Comment
Read more